Diverse Undertakings Ltd. has announced that it is extending its services to include support for veterinary practices in securing their RCVS Practice Standards Scheme (PSS) accreditation.
The company was originally formed to provide business advisory services to small and medium sized enterprises across a range of industry sectors. Its services range from general H.R. advice, health & safety guidance and facilities management to candidate sourcing and call-centre services.
However, with previous experience supporting a substantial veterinary practice in Kent for both employment challenges and PSS accreditation, Company Director Neal Palk decided to extend the company's capability to support other veterinary practices in securing their PSS accreditation.
He says that because the needs of each practice vary, Diverse can adapt its service to reflect both the individual circumstances relating to accreditation as well as the capability/capacity with the practice to undertake necessary tasks itself. By using a network of associates, he says Diverse can call upon other specialities (for example - competitively priced office/building equipment) to smooth the progress to accreditation.
Diverse says it offers a range of transparent pricing options to suit the client which, without the overheads of large consultancies, often result in PSS accreditation being achieved for less cost than a typical administrative temp for a month. Monthly retention fee alternatives for other services are available, beginning at £95+ VAT.
Neal said: "Several organisations offer professional services to the veterinary practice sector, but few can claim to have 'been there, done that' and really understand the climate and culture the sector operates within. Diverse Undertakings Ltd. values its experience in the sector and aims to work with other practices to achieve both accreditation and wider business success."
For more details please contact Neal on 07771 843719, e-mail: info@diverseundertakings.com, or visit: http://www/diverseundertakings.com
Burgess Excel has launched The Excel Food Cube, billed as the first truly 'complete' food for rabbits and guinea pigs, aka 'fibrevores'.
According to the company, it's the first time that rabbit and guinea pig owners will be able to feed a convenient and portion controlled all-in-one food that caters for all of their pets' dental, digestive and emotional needs.
Historically, there has been debate as to whether any one food alone can be classed as 'complete' for these pets. Many foods on the market currently labelled 'complete' only meet the nutritional needs of these pets, because, historically in the world of dog and cat food, that's all a complete food needs to cater for. However, according to Burgess Excel, 72% of vets say that any food labelled as 'complete' for rabbits and guinea pigs should cover dental, digestive and emotional health. To be just 'nutritionally complete' is not enough, because diet accounts for so much more in keeping these pets alive and healthy.
Justin Heaton, Head of Marketing for Burgess Pet Care said "Once again we are incredibly excited and proud to be launching a pioneering new product to the market. Our studies revealed foods labelled 'complete' are generally fed alone, without the hay necessary for fibrevores. As the UK's leading veterinary brand for fibrevores we felt obligated to create a truly healthy, 100% complete food to ensure that pets are being correctly fed. The additional beauty of this product is that it really drives home to fibrevore owners that hay IS food!
The Excel Complete Food Cubes consist of compressed cubes of long fibre Timothy hay for dental and digestive health, together with high fibre tasty nuggets, which contain short fibre, supplements and prebiotics, also necessary for digestive health and to promote foraging. Topped with flowers and beneficial herbs they deliver a visually exciting, innovative solution, inside and out for pet owners."
Justin continued "Excel was the first to expose the myth about 'complete feeds' and identify what the real requirements of these pets are, the first to develop a specific and dedicated feeding plan, the first to identify fibrevores as a subset of small animals and the first to campaign for complete diets to include dental, digestive and emotional health - all of which are why Excel is still the UK's No.1 veterinary recommended food for fibrevores.
However, in today's fast paced and busy world, consumers are always looking for the easiest, least hassle and most convenient ways to feed their pets. To date it has never been easy to find a solution to do this for fibrevores, without compromising their health........ that is until now!"
Burgess says Excel Food Cubes will be available in March but that more information and pre-orders can be taken from your local Burgess representative now. Alternatively, contact Justin Heaton for further information at: Justin.Heaton@burgesspetcare.co.uk
Ticks infected with the bacteria that cause Lyme disease may be considerably more prevalent in the UK than recent estimates indicate, according to new research from the University of Bristol that used pet dogs as 'sentinels' for human disease risk.
Transmitted by ticks, Lyme disease is a debilitating chronic infection which affects a number of animals including humans and dogs. It is caused by the bacterium Borrelia burgdorferi. Clinical signs in humans include a characteristic circular red rash that spreads from the site of the tick bite, followed by a flu-like condition. In dogs, the symptoms can be much more vague and difficult to diagnose. If untreated, the disease progresses to neurological problems and arthritis; chronic forms of the disease can last for many years.
While only occasionally affecting humans, reported cases in the UK are thought to have increased more than fourfold since the beginning of the century - from 0.38 per 100,000 in 2000 to 1.79 per 100,000 in 2009. In 2010 there were 953 reported cases in England and Wales but the level of under-reporting is likely to be considerable.
To obtain a clearer picture of the prevalence of infected ticks, Faith Smith of Bristol's School of Biological Sciences and colleagues recruited veterinary surgeons across England, Scotland and Wales to examine dogs selected at random as they visited veterinary practices. Since pet dogs largely share the same environment and visit the same outdoor areas as their owners, exposure to infected ticks in dogs is likely to provide an index for corresponding risks to humans.
Of 3,534 dogs inspected between March and October 2009, 14.9% had ticks. Of the samples that could be tested, 17 (2.3%) were positive for the Borrelia bacteria. The expected prevalence of infected ticks on dogs is 0.5 per cent, or 481 infected ticks per 100,000 dogs. This suggests that the prevalence of Borrelia in the UK tick population is considerably higher than previously thought.
Faith Smith said: "Lyme disease appears to be a rapidly growing problem in the UK with important health and economic impacts in terms of loss of working hours and potential decrease in tourism to tick hotspots.
"Without considerably better surveillance and routine diagnostic testing, Lyme disease is only likely to become more prevalent. In particular, future warmer winters might well extend the period over which ticks are active seasonally, while growing wild reservoir host populations, such as deer, will allow the tick population to expand."
The study is published today in the journal Comparative Immunology, Microbiology and Infectious Diseases. The research was funded by the Natural Environment Research Council (NERC) and Merial Animal Health Ltd.
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
The British Veterinary Association has reiterated its call for heightened vigilance following confirmation by AHVLA that Schmallenberg virus (SBV) has been detected on four sheep farms in Norfolk, Suffolk and East Sussex.
At this early stage the virus is understood to be vector-borne (although other routes of transmission have not been ruled out) and the clinical signs seen along with meteorological modelling of risk suggests that the four farms were affected during summer/autumn 2011, with congenital defects now becoming visible at lambing time.
Animals imported from the affected areas in northern Europe are also considered to be potentially at risk and their destination in the UK has been identified.
Congenital deformities and nervous defects are seen in newborn lambs, goat kids and calves. Clinical signs in affected cattle include pyrexia (fever), milk drop, and diarrhoea similar to what is often termed 'winter dysentery'. Farmers should be looking out for clusters of these signs within herds and flocks and reporting them to their veterinary surgeon.
Vets who are aware of suspicious clinical signs on their client's farms should report them to AHVLA, SAC or the local DARD divisional veterinary office for further investigation.
AHVLA, SAC and DARD have stated that they are keen to investigate potential cases and there will be no extra charge for the SBV tests that are undertaken, but their approaches are slightly different.
In England, Wales and Northern Ireland AHVLA and AFBI are carrying out SBV-only testing (ie to rule the disease in or out) free of charge but are charging the standard subsidised investigation charge for any additional diagnostic work.
In Scotland any carcases submitted for post mortem examinations are examined at the standard fee and all necessary examinations required by the VIO to investigate the case are included in the fee. SAC is not charging an additional fee for SBV testing.
Carl Padgett, President of the BVA, said: "The confirmation of Schmallenberg virus in sheep flocks in England is a reminder to vets and farmers across the UK to step up vigilance amongst ruminants.
"The BVA would encourage vets to speak to their local AHVLA, SAC or DARD team to discuss any suspect cases and consider submitting specimens for further investigation. We understand that in confirmed cases clinical signs occur in clusters and vets should ensure they know what to look for in both adult and perinatal ruminants.
"While the cases in the south east of England suggest the virus is vector-borne other potential routes of transmission are still being considered. Although the risk of zoonosis is believed to be very low it has not been ruled out and a sensible precautionary approach should be taken by those handling infected animals and specimens."
MSD Animal Health has launched an improved on-farm calf-side scour pathogen testing kit for faster diagnosis of the main infectious organisms implicated in a disease outbreak.
According to the company, the new ScourCheck Rapid Programme promises a 10-minute diagnostic turnaround from faecal sample to result, enabling the veterinary practitioner to offer more timely disease management recommendations without having to wait for a laboratory report. The new kits deliver on-farm identification of rotavirus, coronavirus, cryptosporidium and E. coli K99.
Further details on the ScourCheck Rapid Programme are available from MSD Animal Health account managers.
Kruuse has launched a new extra large size Bovivet Hoof Bandage for use in the treatment of digital dermatitis (DD) in cattle.
According to the company, an estimated 70 per cent of dairy herds suffer with digital dermatitis and, if not treated, it can persist for months, causing pain and lameness to infected cows. Indeed, a paper1 presented at the BCVA 2011 Congress by Prof. N.B. Cook, Clinical Associate Professor at the School of Veterinary Medicine in Madison, USA, said that "lameness can systematically undermine the management of the dairy herd. No other disease has such fundamental and extensive effects on production, reproduction and risk of early herd removal."
The most effective way to fight DD has been found to be the management and treatment of individual animals. Traditional treatments have involved thoroughly washing the infected hoof, applying an antibiotic/drying agent, such as salicylic acid powder, and then applying a dressing that must remain in place usually for three days. However, it can be hard to correctly dose the salicyclic acid powder and there can be complications in ensuring that the dressing is correctly applied at the right pressure and that it stays in place. It can also be a risk to the user's health when mixing the powder.
Kruuse says this can be made easier by using the Bovivet complete Hoof Bandage along with Kruuse Hoof Gel 38%. Firstly, by using a gel, dosing is easy and more accurate, making it more economical per treatment; and, secondly, for the user, it reduces potential health risks from inhalation of the powder when mixing.
Stuart Wilson from Kruuse UK said: "Since the launch in the UK early last year, the hoof bandage has been very well received by cattle vets, but we were told by them that a larger version was needed in some cases. So Kruuse has produced the new extra large size 'red Jimmy Choos for moos'!"
Kruuse has produced the following instructional video to demonstrate the products' ease of use and versatility, and says that the estimated cost per hoof, assuming ten treatments from a bottle of the gel, is £2.71.
Reference
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Elanco Companion Animal Health, maker of Comfortis chewable tablets for dogs, has launched a range of support materials to help educate pet owners on flea infestation and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.
The Range of Comfortis materials features point of sale equipment including free-standing zig-zag display units, window hanging displays, stacking cubes, freestanding easels and leaflet holders as well as client leaflets, waiting room display kits, posters and 20% discount letterheads and postcards for mail-outs. An animation (shown below) is also now available in various formats for veterinary practices to use on their waiting room monitors or websites. The animation, which aims to educate dog owners on flea infestations and complications, covers common risk factors for flea infestations, flea facts including the lifecycle of the flea and encourages pet owners to ask for further information on oral flea control options.
Matthew Rowe, senior product manager at Elanco Companion Animal Health said: "With many pet owners seeking their flea control solutions from other sources, such as the increasingly competitive pet superstores, veterinary businesses need to provide unique preventative healthcare services to their clients to help bond them to the practice and ensure that they return again and again. The new Comfortis support materials will help raise client awareness of the benefits of veterinary prescribed flea treatments and thereby help differentiate veterinary practice flea control solutions from those available in country stores, pet shops, supermarkets and pharmacies."
For further information on Comfortis, or the range of support materials, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@lilly.com.
BSAVA Congress was invaded by Orangemen this year to promote the Vet Charity Challenge (VCC) taking place on 15th September 2012.
Veterinary surgeons and industry colleagues are being encouraged to take part in the one day event in which teams of four will complete a series of physical tasks and puzzle-solving challenges. Teams can choose their own routes which include walking / running, cycling and kayaking stages and can make it as easy or hard as they like.
The Vet Charity Challenge is hoping to raise in excess of £20,000 for Hounds for Heroes; SPANA, and Pet Blood Bank. VCC says it will be a great PR opportunity for practices and an opportunity for team-building.
The event will take place at the Royal Agricultural College, Cirencester and all details may be found on www.vetcharitychallenge.co.uk or by phoning 01727 859259. The VCC will provide training guidelines and sponsorship forms. Places are limited so early booking is advisable. To be sure of a place, practices and business are urged to book their team of four by the deadline of Friday 29th June 2012.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets2.net and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
The Government has announced that it is extending existing dangerous dogs laws to apply to private property, closing a loophole in the current law which only applies to public land.
Jim Paice, Minister of State for Agriculture and Food, said: "We've all heard the stories of snarling dogs not being properly kept under control or heard from health workers, postal workers or social workers who are at risk of serious injury from out of control dogs while just doing their job, attending to people in their homes.
"Today we are announcing a comprehensive package of measures that tackle the problem head on, which will better protect legitimate visitors to private property and will enable the police to take action before someone is hurt or killed."
The plans also put forward proposals to allow the police, when dealing with any dogs which are subject to proceedings under the Dangerous Dogs Act, to take a common sense decision as to whether the dog really needs to be kept away from their owners until the outcome of proceedings.
Mr Paice added: "Our plans must strike the right balance between protecting the public from dangerous dogs and ensuring that safe and properly looked after pets don't need to be wrenched from their home unnecessarily.
"We're giving the police more discretion to take common-sense decisions where dogs are clearly not a threat by ending the requirement that they be seized and kennelled, at great cost to the taxpayer and distress to the owner involved, while a decision is taken on whether to exempt the dog from being destroyed under the Dangerous Dogs Act."
Other measures announced today include:
However, the proposals do not go far enough for Dogs Trust, the dog welfare charity. Clarissa Baldwin, the charity's CEO said: "The Government has spent a great deal of time examining this legislation since it came to power and whilst we accept DEFRA has done their best to look at this issue, unfortunately, their best is no where near good enough. Not good enough to better protect the public or good enough to improve animal welfare.
"Government must tackle this problem head on with completely new legislation rather than just tinkering around the edges. We're extremely disillusioned that there is nothing in the consultation on measures that will actually help to prevent dog attacks, which is surely what the aim of these proposals should be. We seem to be waltzing along on this issue rather than the quick step we need to meaningful reform.
"We consider that the introduction of compulsory microchipping of all dogs, not just those born after a certain date, is the only way that we will see immediate welfare benefits and a reduction in the number of stray dogs in the UK.
"Microchipping will not prevent dog attacks but it will allow the owner of a dangerous dog or a dog that was dangerously out of control to be identified by enforcement agencies. The act of microchipping is also a key intervention, providing an opportunity to advise owners about responsible dog ownership and the law."
Virbac Animal Health has launched a broad spectrum wormer for dogs called Endogard (praziquantel, pyrantel and febantel).
Virbac says Endogard offers treatment against most types of intestinal worms found commonly in dogs. It is presented in two tablet sizes for easy dosage.
Victoria Hudson, Product Manager for Endo and Ectoparasiticides, said: "While we're known for developing innovative products which help practices generate additional revenue streams, we can also support them by offering cost-effective and proven products for routine use.
Endogard is a perfect example. The efficacy of its active ingredients is well-established; it's simple for owners to administer and it's also affordable which will bring them back to the practice. It's an excellent addition to Virbac's strong range of parasite control treatments."
For further information, contact your Territory Manager or call Virbac on 01359 243243.
Burgess Excel has extended its range with what it claims is the UK's most absorbent paper bedding for rabbits, guinea pigs and chinchillas, and a new 'sensitive' variety of nuggets for rabbits and guinea pigs.
Burgess says the bedding is made from environmentally-friendly high quality virgin wood pulp which locks away moisture and liquids quickly and securely. The company also highlights the fact that it is made using advanced, specialised drying and dust extraction techniques to prevent respiratory problems and eye infections which can occur when there is a large amount of dust present in a fibrevore's environment.
The new rabbit and guinea pig nuggets contain 46% Beneficial Fibre with a grain free recipe for delicate digestive systems.
To find out more about the new products, visit www.excelfeedingplan.com/ or contact 0800 413 969.
Colonel Neil Smith has been elected Vice-President of the Royal College of Veterinary Surgeons. He takes up office at RCVS Day on 6 July 2012.
Neil graduated from the Royal Veterinary College in 1989, and was commissioned into the Royal Army Veterinary Corps (RAVC) with the intention of staying for four years. Twenty-two years later, he is now the Director Army Veterinary and Remount Services, effectively the Chief Veterinary Officer for the Army and head of the RAVC, which currently has over 35 Veterinary Officers.
He has held a mixture of clinical, staff and command positions, and has worked in the UK, US and Germany. He has Masters' Degrees in Food Science, Defence Administration and Defence Studies. He has also worked part-time in small animal practice (including the Blue Cross, of which he is now a Trustee), and was heavily involved in the Foot and Mouth Disease outbreak in 2001.
First elected to Council in 2004, Neil was re-elected in 2010 after a short break. He has served on Education, Advisory, Preliminary Investigation and Planning and Resources Committees, and on VN Council (currently Vice-Chairman and Chairman of the Awarding Body).
He has also previously been President of the RVC Student Union Society, the RVC Alumnus Association, Southern Counties, and the Association of Government Veterinarians. He is currently a Council member of the Central Veterinary Society, and has previously sat on the BVA's Veterinary Policy Group.
Neil said: "I am honoured to have been elected as the next Vice-President. The College is about to go through some significant organisational changes, not least because of the proposed legislative reform order. However, I aim to ensure that we remain focused on our primary role in safeguarding the health and welfare of animals committed to veterinary care. The functions of the RCVS are quite diverse, and I am keen that we try to enhance both the profession's and the public's understanding of our remit, including our responsibility for educational, ethical and clinical standards."
Jacqui Molyneux has been confirmed as President, and Dr Jerry Davies as Vice-President, effective July 2012.
Eurovet Animal Health has launched Thyforon Flavoured (levothyroxine sodium, POM-V), which replaces the company's canine hypothyroid treatment Forthyron.
Eurovet says that Thyforon Flavoured has the same clinical efficacy of Forthyron and veterinary surgeons won't need to make any dose adjustments when transitioning to the new product.
However, Thyforon Flavoured, with its palatable formulation, now offers the benefit of being voluntarily accepted by over 70 per cent of dogs in taste trials1. In addition there is a new 800 mcg formulation which gives more prescribing options, particularly for the treatment of large and giant breeds.Thyforon Flavoured comes as easy-break tablets to make dose adjustment straightforward, in an easy-to-dispense blister pack.
Thyforon Flavoured is available now - the person responsible for placing the practice drug order should just ask for Thyforon Flavoured when placing the next drug order and where appropriate, the practice management system should be updated to reflect the new name.
Reference1. Eurovet Animal Health Internal Study report, acceptance study, November 2011
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
Research carried out by the Kennel Club to coincide with Mother's Day has revealed that 35% of dog buyers do not see their new puppy with its mother.
The research also found that one in ten buyers take their puppy home before it is eight weeks old, and that 55% do not see the puppy in its breeding environment.
Bill Lambert, Manager of the Kennel Club Assured Breeder Scheme, said: "March is the most popular month for searching for a puppy, but we are extremely concerned that so many are not seeing their puppy with its mother. Seeing mum not only helps people to find out how their puppy will be likely to turn out in terms of temperament and characteristics, but it also gives them the reassurance that it has been bred in a loving environment where it has been cared for and socialised properly."
Marc Abraham, TV vet and Kennel Club Veterinary Advisor, said: "Puppies depend on their mums in the early weeks of life, not just for milk but she's also critical for developing their socialisation skills which help set them up for life. If a breeder refuses to show the puppy with its mother without very good reason, then buyers should go elsewhere."
The Kennel Club is urging people to see puppies with their mother as part of its Stop Puppy Farming campaign and is joining with Marc Abraham to support the 'Where's Mum?' campaign. Kennel Club research has shown that as many as one in four could unwittingly be buying their puppy from a puppy farm.
The Kennel Club will be running a National Puppy Awareness Week (PAW) from the 8th - 14th September. To find out more visit www.thekennelclub.org.uk/stoppuppyfarming.
Supreme Petfoods has announced that Think Rabbit Fortnight, a campaign to help practices engage with rabbit owners, will run from Monday 21st May to Friday 1st June.
Practices can decide how much they wish to participate in the campaign and can opt to receive goodie bags, a 'Think Rabbit' manual detailing how the practice can be more rabbit-friendly, or take the 'Small Furry' Promise.
The event is being backed by RCVS Exotics Specialist, Molly Varga. She said: "I'd encourage all practices to take part in Think Rabbit Fortnight to help improve the health and welfare of the nation's rabbits."
Supreme says that practices which take part in the Think Rabbit Campaign will also have the opportunity to sign up for Level 1 of its 'Better for Bunnies, Better for Business' programme, which it says can double turnover derived from rabbits through an increase in new clients, average visit transaction spend and attendance rates of existing clients.*
Claire Hamblion, Marketing Manager at Supreme says she hopes that it will really encourage practices to focus on how they can develop protocols and routines that will remove barriers to rabbit owners seeking healthcare advice and presenting their pet for treatment.
Binky - voted Britain's Cutest Bunny - will play a starring role in the Think Rabbit campaign to attract the attention of rabbit owners who will also be asked to nominate their rabbit as a VIP (Very Important Pet). Claire said: "Our VIP won't necessarily be the most prettiest, fastest or cleverest bunny but one that has special qualities in the eyes of its owner. I hope vets and nurses will help spread the word and maybe even nominate some very important patients."
To sign up for Think Rabbit Fortnight, visit www.supremepetfoods.com/thinkrabbit, email thinkrabbit@companionconsultancy.com, or telephone 01284 761107.
*Supreme - Better for Bunnies, Better for business programme, Onswitch March 2012
The Federation of European Companion Animal Veterinary Associations (FECAVA) has launched the European Journal of Companion Animal Practitioners (EJCAP) Online, the first European fully online veterinary journal.
As the official journal of the FECAVA, the EJCAP online is exclusively available to members of national companion animal veterinary associations which are in turn members of FECAVA (which include the BSAVA).
According to FECAVA, the EJCAP online will continue to offer the sort of high quality CPD articles which the magazine was known for during its 21 year history in print. However it will now also be able to offer rich media, such as videos with clinical presentations, endoscopy and ultrasound recordings, diagnostic and surgical techniques, interviews with experts, conference presentations as well as slide shows, interactive quizzes, surveys and animations.
The frequency of publication has also been increased, from three to four issues per year, including one special issue.
The EJCAP online is available in two languages - English and Spanish. More languages are planned in future.
Simon Orr, FECAVA president, said: "Since the momentous decision to publish EJCAP online was taken by our Council in Lille in 2009, we are delighted to offer our members this new and engaging way to gain new information and skills.
As we start work on the next issues, we invite all our readers to give us feedback on this first volume of EJCAP online. On the last spread (page) there is a link to a survey on this new format, to help us further improve and optimize EJCAP online."
To register, visit EJCAP online (www.fecava.org/ejcap).
Clinicians at the Queen Mother Hospital for Animals at the Royal Veterinary College have become the first team in the UK to successfully treat acromegaly in a cat with hypophysectomy surgery.
According to the RVC, this make it the first centre in the UK, and only the fourth in the world, to offer this procedure. The patient groups that might benefit from this RVC-exclusive procedure include cats and dogs with non-functional pituitary tumors, cats and dogs with hyperadrenocorticism (Cushing's disease) and cats with acromegaly or hypersomatotropism.
The RVC says removing the pituitary gland and the associated tumour which causes acromegaly or hyperadrenocorticism is the gold standard treatment in humans suffering from these diseases since it offers the greatest chance of a complete cure for the disease.
Prior to the RVC offering surgical treatment, the only treatment options available for acromegalic cats in the UK were radiation therapy or simply treatment of the resulting diabetes mellitus. The latter can prove extremely difficult and frustrating and the former unpredictable, unreliable and/or ineffective. Even when a complete response to the radiation therapy eventually occurs, hormonal abnormalities usually persist.
Dr Stijn Niessen, leading the hypophysectomy team at the Royal Veterinary College, said: "I'm extremely proud to be able to offer this unique surgery for the first time in the UK at the RVC. As a relatively new and innovative procedure in veterinary medicine there are risks involved, as is recognised with every form of neurosurgery of this level. However, despite these risks, this surgery does offer owners a chance for the best possible result for their pet using a single procedure. Hypophysectomy therefore represents the most elegant treatment method currently available enabling complete removal of the brain tumor and normalisation of damaging excessive hormone levels that are causing hormonal diseases like acromegaly and hyperadrenocorticism.
"Especially when a pituitary tumor is diagnosed late, the alternative treatment method of radiation therapy might well take too long to take effect and devastating neurological signs might occur due to the pressure of the pituitary tumor on the surrounding brain. In such cases, hypophysectomy can make an instant difference in relieving that pressure. However, in general, we would advocate the procedure to be considered as soon as possible following diagnosis, thereby preventing the animal's body from becoming more and more negatively affected by the excessive hormone levels associated with pituitary diseases like acromegaly and hyperadrenocorticism."
Dr. Niessen, a European Veterinary Specialist in Internal Medicine with research interests in diabetes and endocrinology and world-expert in acromegaly, will be selecting the patients suitable for the new treatment, preparing them for surgery and managing the aftercare programme. The longer-term aftercare programme will include hormone replacement treatment administered through eye-drops (usually temporarily) and tablets (permanent) to manage the hormone production lost through removal of the pituitary gland.
The surgery itself will be performed by Patrick Kenny, a European and American Specialist in Veterinary Neurology and Neurosurgery.
The RVC says the surgery would not be possible without the multidisciplinary approach at the Queen Mother Hospital for Animals, which includes the Internal Medicine, Neurology and Neurosurgery, Diagnostic Imaging, Anaesthesia and Emergency and Critical Care teams as well as a team of highly qualified nurses.
To support ongoing research in this field, the Royal Veterinary College is offering free blood tests for all diabetic dogs and cats which include fructosamine evaluation and screening tests for the presence of acromegaly in cats. Cats that record high hormone levels indicative of acromegaly will qualify to undergo a free CT scan for confirmation. If acromegaly is confirmed, all possible treatment options will be discussed with the client, including the hypophysectomy procedure. To request a free blood test for a patient please visit: www.rvc.ac.uk/cic
Veterinary surgeons currently managing a cat or dog with a pituitary tumor who are considering referral of this case can also contact Dr Stijn Niessen for further information at the QMHA on 01707 666365 or at qmhreception@rvc.ac.uk
A Europe-wide survey has found that speed and accuracy are the key features that farm animal veterinary surgeons and farmers want from diagnostic tests
More than 334 individuals from 8 countries were asked about their current usage and knowledge of diagnostics, and asked what they would like to see in the future. Greater accuracy was the number one need among veterinary surgeons, mentioned by 37%, followed by more speed (22%); cost savings (16%) and greater confidence in the results (8%) were other features that they would like to see improved.
The survey, which was commissioned by global biotechnology company Life Technologies, showed that most test results are currently available in one to three days, but still a significant proportion have to wait three to six days for results (39%) or even more than six days (20%). Only 10% currently get their results within 24 hours.
Although many of the vets were aware of modern molecular diagnostics tests such as PCR (polymerase chain reaction) which generally offer quicker results than culture testing, most did not know which were used most often. The vast majority of farmers were happy to leave the decision on type of diagnostics test to their veterinarian.
Frederic Bar, Sr. Marketing Manager EMEA at Life Technologies said: "The results show that veterinarians are looking for the speed and accuracy that modern molecular diagnostics, such as PCR, can provide, but this technology is still not being used as widely as it could be."
"One way in which veterinarians could get faster, more accurate-results would be to specify PCR when they submit samples to diagnostic laboratories.
"Diagnostics have really moved on in recent years and the modern tests can give very reliable results, often in just one day, so veterinarians and farmers can make herd health decisions more quickly."
The survey found that BVD, IBR and MAP tests were the most commonly used in cattle, while PRRS, Influenza A and Salmonella topped the list for swine. For sheep and goats, Salmonella, MAP and Chlamydia were the most frequently mentioned tests; for horses, EHV, equine infectious anaemia and Salmonella were most common. Avian influenza was by far the most commonly tested disease in poultry.
Merial Animal Health has announced the launch of its new feline vaccine Purevax Rabies in the UK and Ireland.
Merial says the product offers a simple but elegant solution to rabies vaccination, without the need for adjuvant. According to the company, the non-replicative vector is processed by the cat's immune system in the same way as a live virus, triggering both a powerful cell mediated and humoral response without the need for adjuvant. However, because the vector cannot replicate effectively in mammalian cells, there is no risk of any reversion to virulence.
Merial's Veterinary Technical Manager Kevin Whelan, said: "This is a perfect complement to our existing range of advanced technology vaccines, which already offer the benefits of highly effective protection, including updated FCV strains, without the need for adjuvant. It also represents Merial's continued commitment to the development of innovative products for the animal health market".
The vaccine is licensed for use in cats from 12 weeks of age, and administration of a single injection has been shown to provide protection against disease.
Contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.
BCF has announced a number of special deals available on a variety of ultrasound and X-ray products.
With the launch of the new Mindray DP-50 ultrasound scanner, available exclusively from BCF, the company is offering a free trolley and a year's supply of gel.
If you buy a Carestream Vita CR X-ray system and generator from BCF, the company will update your X-ray protection with 3 gowns and 2 thyroid protectors (worth £600, €750) free.
Purchase an Easi-Scan with one battery, and you'll get a second battery and carry bag for free.
Buy an equine DR X-ray system and you'll receive £1,000 (€1,250) to spend on Podoblocks accessories.
Call +44 (0)1506 460 023 or visit www.bcftechnology.com for further information. Offers valid until 31st June.
Edinburgh-based charity the Global Alliance for Livestock Veterinary Medicines (GALVmed) has announced three drug discovery contracts in an effort to combat animal African Trypanosomosis (AAT), a disease which is estimated to cost Africa US$5billion a year.
Animal African trypanosomosis, transmitted by the tsetse fly, is a parasitic disease which affects livestock, resulting in a chronic illness which often ends in death. An estimated 50 million cattle and 70 million sheep and goats are at risk, with around 3 million cattle dying annually from the disease.
AAT causes economic losses in livestock, reducing meat and milk production and leaving animals so weak they are unable to help cultivate land. It affects over 10 million square kilometres of fertile land spread across nearly 40 countries in Africa and therefore has a huge impact on food and nutritional security and livelihoods across the continent.
The drugs that are currently used were developed in the 1950s and 60s and drug resistance is now a commonly reported problem. With few other options available, these drugs are the most important method of controlling the disease.
In May 2011 the Department for International Development (DfID) awarded GALVmed 30 month grant for £8million to facilitate the development of drugs, diagnostics and potential vaccines for the control of AAT.
The first contract was awarded to Anacor Pharmaceuticals Inc., a California based biopharmaceutical company established in 2002.
As part of a Drugs for Neglected Diseases Initiative (DNDi) supported project, Anacor and their partners discovered a series of compounds to combat the human form of AAT, Human African Trysanosomsis (HAT). A number of compounds produced under this programme have properties which could make them suitable for the treatment and prevention of animal AAT. These relevant compounds will now be screened for efficacy and safety under the GALVmed contract.
The second and third contracts have both been awarded to the College of Life Sciences at the University of Dundee, one of Europe's top-ranked universities for life science research.
Dr Kevin Read, who is Head of Drug Metabolism and Pharmokinectics at the drug Discovery Unit is leading a piece of drug discovery and development research, which aims to develop new drugs for the treatment and possible prevention of AAT in cattle, and also a diagnostic test for use in the field. This builds on the university's work on HAT and drugs that were unsuitable for human treatment are now being re-evaluated as potential drugs for cattle.
Dr Read said: "I am very excited to be working in partnership with GALVmed to apply our extensive drug discovery expertise in HAT to identify and bring forward new potential drugs for the treatment and prevention of AAT. The new project offers an exciting opportunity to reposition compounds showing great promise for the treatment of first stage HAT into AAT, thus improving food security in some of the poorest countries in sub-Saharan Africa."
Woodley Equipment Company has launched RapidVet-H IC a testing kit for identifying blood types in cats and dogs.
RapidVet-H IC uses immuno-chromatographic technology to identify the feline blood groups: Type A, Type B and Type AB, and the canine blood groups: DEA 1.1 Negative and DEA 1.1 Positive
According to Woodley, this is the first such system to present a positive result as a red line on a white background, thus making it very easy to read.
RapidVet-H IC consists of a hand-held device containing three membranes and uses a diluent specific for these tests. It uses whole blood, or packed red blood cells. It is a cell capture assay, so patients exhibiting auto-agglutination or low PCV can be typed. The system displays results in 5-10 minutes.
For more information about RapidVet-H IC, email: sales@woodleyequipment.com, or call Woodley on +44 (0) 1204 669033 Option 1.